Combined anti-osteoplastic, anti-inflammatory, immunomodulatory and angiostatic treatment in patients (pts) with castration-refractory prostate cancer (CRPC): Biologic features during therapy interruption and tumor progression

Reichle, A. and Vogelhuber, M. and Feyerabend, S. and Suedhoff, T. and Schulze, M. and Huebner, J. and Oberneder, R. and Ruebel, A. and Birkholz, K. and Bakhshandeh-Bath, A. and Andreesen, R. (2012) Combined anti-osteoplastic, anti-inflammatory, immunomodulatory and angiostatic treatment in patients (pts) with castration-refractory prostate cancer (CRPC): Biologic features during therapy interruption and tumor progression. ONKOLOGIE, 35 (suppl6). p. 181. ISSN 0378-584X

Full text not available from this repository.
Item Type: Article
Subjects: 600 Technology > 610 Medical sciences Medicine
Divisions: Medicine > Lehrstuhl für Innere Medizin III (Hämatologie und Internistische Onkologie)
Depositing User: Petra Gürster
Date Deposited: 25 May 2020 10:47
Last Modified: 25 May 2020 10:47
URI: https://pred.uni-regensburg.de/id/eprint/17985

Actions (login required)

View Item View Item
pred is powered by EPrints 3.4 which is developed by the School of Electronics and Computer Science at the University of Southampton. More information and software credits.